Redpoint Investment Management Pty LTD Vertex Pharmaceuticals Inc Transaction History

Redpoint Investment Management Pty LTD

$684 Million
Q3 2022

A detailed history of Redpoint Investment Management Pty LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 5,950 shares of VRTX stock, worth $2.99 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

5,950

Previous 6,981 14.77%

Holding current value

$2.99 Million

Previous $1.97 Million 12.4%

% of portfolio

0.25%

Previous 0.23%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$273.83 - $305.53 $282,318 - $315,001	-1,031 Reduced 14.77%	5,950 $1.72 Million
Q2 2022 Jul 08, 2022	SELL	$234.96 - $292.55 $17,622 - $21,941	-75 Reduced 1.06%	6,981 $1.97 Million
Q1 2022 Apr 13, 2022	SELL	$221.42 - $260.97 $29,006 - $34,187	-131 Reduced 1.82%	7,056 $1.84 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $25,575 - $28,621	-141 Reduced 1.92%	7,187 $1.3 Million
Q2 2021 Aug 05, 2021	BUY	$187.49 - $221.1 $18,936 - $22,331	101 Added 1.4%	7,328 $1.48 Million
Q1 2021 Apr 13, 2021	BUY	$207.02 - $241.31 $96,885 - $112,933	468 Added 6.92%	7,227 $1.55 Million
Q4 2020 Jan 13, 2021	SELL	$207.01 - $276.09 $94,396 - $125,897	-456 Reduced 6.32%	6,759 $1.6 Million
Q3 2020 Oct 09, 2020	SELL	$255.65 - $303.1 $3.07 Million - $3.64 Million	-12,000 Reduced 62.45%	7,215 $1.96 Million
Q2 2020 Jul 17, 2020	SELL	$225.48 - $295.8 $318,828 - $418,261	-1,414 Reduced 6.85%	19,215 $5.58 Million
Q1 2020 Apr 22, 2020	SELL	$199.77 - $247.81 $33,361 - $41,384	-167 Reduced 0.8%	20,629 $4.91 Million
Q4 2019 Feb 25, 2020	SELL	$166.71 - $223.91 $103,026 - $138,376	-618 Reduced 2.89%	20,796 $4.55 Million
Q3 2019 Nov 26, 2019	SELL	$166.23 - $187.09 $63,167 - $71,094	-380 Reduced 1.74%	21,414 $3.63 Million
Q2 2019 Aug 07, 2019	SELL	$164.61 - $190.37 $47,407 - $54,826	-288 Reduced 1.3%	21,794 $4 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $183,213 - $217,869	1,119 Added 5.34%	22,082 $4.06 Million
Q2 2018 Aug 09, 2018	BUY	$145.72 - $169.96 $68,342 - $79,711	469 Added 2.29%	20,963 $3.56 Million
Q4 2017 Aug 09, 2018	BUY	$137.28 - $155.55 $2.81 Million - $3.19 Million	20,494	20,494 $3.07 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.

Account

Redpoint Investment Management Pty LTD Vertex Pharmaceuticals Inc Transaction History